MyFinsight
Home
Blog
About
Contact
Download
Download image
Other Activities
$230M
International Markets
$512M
Europe
$1,306M
US
$2,397M
Net revenues
$4,444M
Gross profit
$2,379M
Cost of sales
$2,065M
Adjustments to valuation
allowances on deferred tax...
$47M
Changes in unrecognized
tax benefits...
$15M
Other (amount)-Swiss
Federal Tax...
$1M
Adjustments to valuation
allowances on deferred tax...
$35M
Other (amount)-Malta
Tax Authority
$2M
Statutory tax rate
difference (amount)-Malta...
$9M
Adjustments to valuation
allowances on deferred tax...
$10M
something is missing
-$189M
Operating income (loss)
$378M
Other loss (income)
-$3M
Legal settlements and
loss contingencies
$161M
Other asset
impairments, restructuring...
$505M
Intangible assets
impairments
$37M
General and
administrative expenses
$337M
Selling and marketing
expenses
$704M
Research and development
expenses, net
$255M
Share in (profits)
losses of associated...
$105M
Income taxes (benefit)
-$234M
Income (loss) before
income taxes
$142M
Adjustments to valuation
allowances on deferred tax...
-$8M
Statutory tax rate
difference (amount)-Swiss...
-$40M
Reduced rate due to
imputation system...
$22M
Other
(amount)-Revenue Commissioners...
-$1M
Financial expenses net
-$236M
Net income (loss)
$481M
Net income (loss)
attributable to teva
$481M
Back
Back
Income Statement
source: myfinsight.com
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)